Physician profile
John H Benner
NPI 1114960564
$637.14
in general payments reported to CMS, 2019-2025
11 companies · $14.58 in 2025
The $14.58 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $85.22 · 2021: $132 · 2022: $108 · 2023: $70.37 · 2024: $93.21 · 2025: $14.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $246.22 | 2019-2025 | Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $118.83 | 2022-2024 | Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $58.18 | 2020-2021 | |
| Eclipse Technology Solutions INC. | $53.14 | 2023 | |
| Smith+Nephew, INC. | $46.50 | 2019 | |
| Bioventus LLC | $30.67 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $23.27 | 2024 | Dysport |
| Ucb, INC. | $19.87 | 2019 | |
| Ermi LLC | $16.91 | 2020 | |
| Amgen INC. | $11.78 | 2020 | |
| Orthogenrx INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Benner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.